Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 12,594.6%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,594.61% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 2,656.81% |
WW International, Inc Common Stock (WW) | 2,144.27% |
DeFi Development (DFDV) | 2,041.48% |
Oncology Institute (TOI) | 1,285.62% |
Abivax SA American Depositary Shares (ABVX) | 1,163.67% |
FiEE (FIEE) | 1,037.61% |
Abits (ABTS) | 893.73% |
180 Life Sciences (ATNF) | 838.55% |
Global Interactive Technologies (GITS) | 817.01% |
Better Home & Finance (BETR) | 789.02% |
Lizhi (SOGP) | 778.79% |
Above Food Ingredients Inc Common Stock (ABVE) | 729.09% |
Nova Lifestyle I (NVFY) | 727.53% |
Nanobiotix (NBTX) | 688.42% |
TMC the metals (TMC) | 635.09% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 605.28% |
Palvella Therapeutics (PVLA) | 568.99% |
mF International Limited Ordinary Shares (MFI) | 568.01% |
Newegg Commerce (NEGG) | 559.88% |
ThredUp (TDUP) | 550% |
Dominari (DOMH) | 548.08% |
I-Mab (IMAB) | 514.12% |
NioCorp Developments Ltd Common Stock (NB) | 510.69% |
